Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editors
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Kiara N Berríos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Group in Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: CRISPR-Associated Protein 9, Cytidine Deaminase, Escherichia coli, Gene Editing. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHGRI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
The partnership of DNA deaminase enzymes with CRISPR-Cas nucleases is now a well-established method to enable targeted genomic base editing. However, an understanding of how Cas9 and DNA deaminases collaborate to shape base editor (BE) outcomes has been lacking. Here, we support a novel mechanistic model of base editing by deriving a range of hyperactive activation-induced deaminase (AID) base editors (hBEs) and exploiting their characteristic diversifying activity. Our model involves multiple layers of previously underappreciated cooperativity in BE steps including: (i) Cas9 binding can potentially expose both DNA strands for ‘capture’ by the deaminase, a feature that is enhanced by guide RNA mismatches; (ii) after strand capture, the intrinsic activity of the DNA deaminase can tune window size and base editing efficiency; (iii) Cas9 defines the boundaries of editing on each strand, with deamination blocked by Cas9 binding to either the PAM or the protospacer and (iv) non-canonical edits on the guide RNA bound strand can be further elicited by changing which strand is nicked by Cas9. Leveraging insights from our mechanistic model, we create novel hBEs that can remarkably generate simultaneous C > T and G > A transitions over >65 bp with significant potential for targeted gene diversification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate Group in Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Graduate Group in Cell and Molecular Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Rahul M Kohli
Förderung
- NHGRI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- Penn Center for Genomic Integrity
- NIH
- NSF
Zitieren
APA
Berríos, K. N., Barka, A., Gill, J., Serrano, J. C., Bailer, P. F., Parker, J. B., Evitt, N. H., Gajula, K. S., Shi, J., & Kohli, R. M. (2024). Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editors. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae024
Vancouver
Berríos KN, Barka A, Gill J, Serrano JC, Bailer PF, Parker JB, et al. Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editors. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae024
BibTeX
@article{Berros2024,
author = {Berríos, Kiara N and Barka, Aleksia and Gill, Jasleen and Serrano, Juan C and Bailer, Peter F and Parker, Jared B and Evitt, Niklaus H and Gajula, Kiran S and Shi, Junwei and Kohli, Rahul M},
title = {Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editors},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae024}
}
EUVIMED